Company Profile
LeMaitre Vascular Stock Price, News & Analysis
- Ticker:
- LMAT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
80.82 USD (+2.30%)
Close
Last updated: August 6, 2026
2.09B USD
Market cap
Why the stock is moving
The latest monitored company update is “LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference.” The corresponding closing-price reaction is not yet available.
Company overview
Business overview
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, LeMaitre sits in niche medtech.
Business Model Characteristics
Revenue comes from surgeon adoption, recurring product use, and steady growth in vascular procedures.
Position Within the Biotechnology Landscape
LeMaitre is a disciplined medtech name that trades on procedural demand and product execution rather than biotech catalysts.
Future catalysts
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery. The stock improves when recurring demand stays steady.
Recent news
- 01
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Source: LeMaitre Vascular
- 02
LeMaitre Q2 2026 Financial Results
Source: LeMaitre Vascular
- 03
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Source: LeMaitre Vascular
- 04
LeMaitre to Participate at Upcoming Investor Conferences in June
Source: LeMaitre Vascular
- 05
LeMaitre to Present at the Bank of America Healthcare Conference
Source: LeMaitre Vascular
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LeMaitre Vascular (LMAT)?
LeMaitre Vascular (LMAT) most recently closed at 80.82 USD, a +2.30% move versus the previous session.
What is the market cap of LeMaitre Vascular (LMAT)?
LeMaitre Vascular currently has a market capitalization of 2.09B USD on BioPharmSignal.
What does LeMaitre Vascular do?
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
On which exchange is LMAT stock listed?
LeMaitre Vascular (LMAT) is associated with NASDAQ, United States, Biopharma.
What is LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
Which conditions is LeMaitre Vascular targeting with LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
How does LeMaitre Vascular describe recent progress with LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
What is Vascular?
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products.